HeraMED update on user growth for HeraCARE platform

HeraMED Limited (ASX:HMD) has reported a significant increase in user growth for its innovative HeraCARE platform, with over 3,800 expectant mothers onboarded and more than 710 active users as of 30 September 2024. The company's successful launch at Broward Health in Florida has been a primary driver behind this growth, with 207 pregnant mothers onboarded in the first 100 days.

Executive commentary on user growth and platform enhancements

It's incredibly exciting to collaborate with customers that share an aligned vision to change maternity and pregnancy care outcomes. A key pillar in our strategic plans was to be customer first and ensure HeraCARE is 'fit for purpose'. Our platform enhancements have focused on workflow refinement, smart notification configuration, chat and telehealth implementation, care plan design, and notifications for complex care populations, and to see our user growth be underpinned by this customer focus is very rewarding. We have further interest from other Florida based health systems based on our success at Broward who we are engaging with. We are at the start of our commercialisation journey and our pipelines continue to expand and our evidence base continues to grow. We look forward to updating shareholders on further customer success in the coming weeks.

Summary of HeraMED's user growth and platform enhancements

HeraMED (ASX:HMD) has experienced a surge in user growth for its HeraCARE platform, with over 3,800 expectant mothers and 710 active users as of 30 September 2024. The successful implementation at Broward Health in Florida has been a key driver of this growth, with 207 pregnant mothers onboarded in the first 100 days. The company's focus on platform enhancements, including the establishment of 9 defined care plans and expansion of postpartum care, has contributed to the platform's ability to seamlessly integrate into existing healthcare systems. Additionally, HeraMED's grant strategy framework and expansion of market opportunities in Florida reflect its commitment to sustainable funding and continued growth. With a growing customer pipeline and evidence base, HeraMED is poised to further enhance maternity and pregnancy care outcomes.